KEYSTONE BIOMEDICAL INC has a total of 26 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are EPICYTE PHARMACEUTICAL INC, MITTENZWEI HELLMUT and COY DAVID HOWARD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United States | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | China | 3 | |
#7 | Mexico | 2 | |
#8 | EAPO (Eurasian Patent Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Basic materials chemistry | |
#4 | Environmental technology | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Horwitz Lawrence D | 11 |
#2 | Hudspeth James P | 7 |
#3 | Buswell Richard L | 6 |
#4 | Levy Stuart G | 6 |
#5 | Stearns Jay F | 6 |
#6 | Geraci Leo S | 6 |
#7 | Gaudioso Larry A | 6 |
#8 | Horwitz Kathryn B | 5 |
#9 | Weglarz Michael A | 5 |
#10 | Weglarz M A | 1 |
Publication | Filing date | Title |
---|---|---|
US6063919A | Process for the synthesis of exochelins | |
US5952492A | Chemical synthesis of exochelins | |
AU6322898A | Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation | |
US5837677A | Method for the treatment of cancer with Exochelins of Mycobacterium tuberculosis |